Author

Gert De Hertogh 1

1 Univ of Leuven,Leuven,Belgium

AN ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT HISTOLOGICAL REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS PATIENTS

Marietta Iacucci, Tommaso Lorenzo Parigi, Rocio del Amor, Pablo Meseguer, Giulio Mandelli, Anna Bozzola, Alina Bazarova, Pradeep Bhandari, Raf Bisschops, Silvio Danese, Gert De Hertogh, Jose Ferraz, Martin Götz, Enrico Grisan, Xianyong Gui, Bu Hayee, Ralf Kiesslich, Mark Lazarev, Remo Panaccione, Adolfo Parra-Blanco , L

COMPARISON OF GEBOES SCORE AND SIMPLIFIED GEBOES SCORE WITH MAYO ENDOSCOPIC SUBSCORE IN PATIENTS WITH RECENT DIAGNOSIS OF ULCERATIVE COLITIS: A RETROSPECTIVE STUDY.

Aranzazu Jauregui Amezaga, Auke Geerits, Yannick Das, Bart Lemmens, Talat Bessissow, Triana Lobaton Ortega, Marc Ferrante, Raf Bisschops, Karel Geboes, Gert De Hertogh, Severine Vermeire

Effects of Ustekinumab Maintenance Therapy on Endoscopic Improvement and Histologic Improvement in the UNIFI Phase 3 Study in Ulcerative Colitis

Katherine Li, Joshua R. Friedman, Colleen W. Marano, Hongyan Zhang, Feifei Yang, William Sandborn, Bruce E. Sands, Brian G. Feagan, Laurent Peyrin-Biroulet, Gert De Hertogh

ETROLIZUMAB TREATMENT IMPROVES HISTOLOGICAL ACTIVITY AS ASSESSED BY BOTH THE ROBARTS HISTOPATHOLOGY AND NANCY HISTOLOGICAL INDICES

Laurent Peyrin-Biroulet, Brian G. Feagan, Gert De Hertogh, David T. Rubin, Romeo Maciuca, Jacqueline McBride, Udaysankar Arulmani, Alexis Scherl

HISTOLOGIC MEASURES OF MUCOSAL HEALING CORRELATE WITH ENDOSCOPIC MEASURES OF DISEASE ACTIVITY AT BASELINE AND FOLLOWING INDUCTION THERAPY WITH THE JAK1 INHIBITOR FILGOTINIB IN ACTIVE CROHN’S DISEASE: RESULTS FROM FITZROY STUDY

Walter Reinisch, Geert R. D'Haens, Gert De Hertogh, Annegret Van der Aa, Jenny Zhang, Chantal Tasset, Chohee Yun, Adrian Serone, Brian G. Feagan, William Sandborn, Severine Vermeire

HISTOLOGICAL AND ENDOSCOPIC ASSESSMENT IN ULCERATIVE COLITIS: RESULTS FROM THE PURSUIT TRIAL

Rick Strauss, Brian G. Feagan, Jean-Frederic Colombel, Colleen W. Marano, Stephen Xu, Laurent Peyrin-Biroulet, Gert De Hertogh, William Sandborn

INCREASED EXPRESSION OF T-CELL-ASSOCIATED GENES IN BASELINE BIOPSIES FROM TNF ANTAGONIST NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO UNDERGO REMISSION IN RESPONSE TO ETROLIZUMAB IN A PHASE II TRIAL

Gaik Tew, Jason Hackney, Deena Gibbons, Christopher Andrew Lamb, Diana Luca, Jackson Egen, Severine Vermeire, John Charles Mansfield, Brian G. Feagan, Julian Panés, Daniel C. Baumgart, Stefan Schreiber, Iris Dotan, William Sandborn, John A. Kirby, Peter Irving, Gert De Hertogh, Gert Van Assche, Paul Rutgeerts, Sharon O'B

Mucosal capillary pattern recognition based on automated image analysis during endoscopy accurately detects histological remission in ulcerative colitis

Peter Bossuyt, Gert De Hertogh, Tom Eelbode, Severine Vermeire, Raf Bisschops

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Caroline Looney, Franklin Fuh, Meina Tang, Xiaohui Wei, Mary E. Keir, Gaik Tew, Jeffrey Eastham-Anderson, Lauri Diehl, Azucena Salas, Gert De Hertogh, Steven Francom, Houston Gilbert, Diana Luca, Jackson Egan, Severine Vermeire, John Charles Mansfield, Christopher Andrew Lamb, Brian G. Feagan, Julian Panés, Daniel C. Bau

PROGNOSTIC VALUE OF COMPLETE REMISSION IN PATIENTS WITH MUCOSAL HEALING IN ULCERATIVE COLITIS

Triana Lobaton Ortega, Talat Bessissow, Gert De Hertogh, Alexandra Ruiz Cerulla, Severine Vermeire, Gert Van Assche, Raf Bisschops, Jordi Guardiola Capon, Marc Ferrante

Item 1 - 10 / 26
1
2 3